|
|
|
|
|
|
|
Tekla Life Sciences Investors (HQL)
|
|
18.97 0 (0%)
|
05-18 16:02
|
|
Open:
|
18.91
|
Pre. Close:
|
18.97
|
|
High:
|
19.0518
|
Low:
|
18.91
|
|
Volume:
|
50,079
|
Market Cap:
|
417M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
19.068 - 19.16
|
19.16 - 19.24
|
|
Low:
|
18.686 - 18.794
|
18.794 - 18.887
|
|
Close:
|
18.809 - 18.976
|
18.976 - 19.119
|
|
|
|
Technical analysis (as of: 2018-05-18 4:34:10 PM)
|
|
Overall:
|
|
|
Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.
|
|
Target:
|
Six months: 22.66 One year: 26.47
|
|
Support:
|
Support1: 18.54 Support2: 18.01
|
|
Resistance:
|
Resistance1:
19.40 Resistance2: 22.66
|
|
Pivot:
|
18.62 
|
|
Moving Averages:
|
MA(5): 18.97 MA(20): 18.64 
MA(100): 19.57 MA(250): 20.22
|
|
MACD:
|
MACD(12,26):
-0.02 Signal(12,26,9): -0.11
|
|
%K %D:
|
%K(14,3): 85.80 %D(3): 83.67
|
|
RSI:
|
RSI(14): 53.26
|
|
52-Week:
|
High: 22.24
Low: 18.01 Change(%): -7.3
|
|
Average Vol(K):
|
3-Month: 5764
10-Days 4977
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.HQL has closed below upper band by 21.0%. Bollinger Bands are 20.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
2018-04-30T14:53:00-04:00
Tekla World Healthcare Fund Paid Distribution
2018-04-30T14:53:00-04:00
Tekla Healthcare Opportunities Fund Paid Distribution
2018-04-26T11:07:36-04:00
Weekly CEF Roundup: April 13, 2018
2018-04-21T09:52:39-04:00
Closed-End Fund BME - Another Way To Play The Healthcare Sector
2018-04-20T01:46:56-04:00
Weekly CEF Roundup: DSU Tender Offer Expires
2018-04-18T18:44:17-04:00
Closed-End Fund THQ: Large-Cap Healthcare Stocks At An 8% Yield
2018-04-10T05:36:55-04:00
Seeking Out Innovators In Cancer Therapy
2018-04-09T09:43:04-04:00
The Bio-Tech 'Wreck': General, And Company-Specific Analysis
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
